EAHAD Events

The recent withdrawal of Roctavian from the market has raised important questions for clinicians, patients, and healthcare systems involved in the management of haemophilia A gene therapy. As the first…

Gene therapy is transforming the treatment landscape of hemophilia, but major questions remain regarding its use in patients with current or past inhibitors. In this webinar, leading experts will discuss…